You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
Every organization has its proprietary resources: compounds, data, knowledge and know-how. At the early stage of drug discovery, pooling these resources can yield results that surpass what organizations could otherwise achieve. Stakeholders in pharmaceutical research need each other - and their proprietary resources - to take their work and achievements to the next levels.
TI Pharma targets priority medicine research by facilitating and safeguarding the flow of competitive information between partners. Guided by TI Pharma's expertise, resources can be effectively and safely shared.
“What TI Pharma can deliver from collaborations is more efficient healthcare, faster time to market and quicker patient benefit.”